Denali Therapeutics Inc. · NASDAQ:DNLI
Baillie Gifford & Co reported a 8.60% stake in Denali Therapeutics Inc. (Schedule 13G/A)
Event Dec 31, 2024 · Filed Feb 12, 2025
Baillie Gifford & Co reported a 8.60% stake in Denali Therapeutics Inc., 12,313,931 shares, as a passive investor on Dec 31, 2024. Filed Feb 12, 2025 (Schedule 13G/A).
- Stake
- 8.60%
- Shares
- 12,313,931
- Intent
- Passive
- What changed
- Stake changed
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BAILLIE GIFFORD & CO | 8.60% | 12,313,931 |
Source
Related
- Denali Therapeutics Inc.
- Baillie Gifford & Co
- Denali Therapeutics Inc. shareholders
- Schedule 13G/A · Baillie Gifford & Co · Aug 4, 2026
- Schedule 13G · Baillie Gifford & Co · Aug 8, 2025
- Schedule 13G/A · Baillie Gifford & Co · Feb 12, 2025
- Form 4 · Chin Peter Scott · Sep 9, 2026
- Form 4 · Thornberry Nancy · Sep 4, 2026
- Form 4 · Schuth Alexander O. · Sep 3, 2026
- Form 4 · Watts Ryan J. · Aug 14, 2026
- Form 4 · Schuth Alexander O. · Aug 13, 2026